Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SHINKAI T' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 72 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mizushima, H; Uchiyama, E; Nagata, H; Matsuno, Y; Sekiguchi, R; Ohmatsu, H; Hojo, F; Shimoda, T; Wakao, F; Shinkai, T; Yamaguchi, N; Moriyama, N; Kakizoe, T; Abe, K; Terada, M
      Japanese experience of telemedicine in oncology

      INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
    2. Ohmori, O; Shinkai, T; Hori, H; Kojima, H; Nakamura, J
      Polymorphisms of mu and delta opioid receptor genes and tardive dyskinesiain patients with schizophrenia

      SCHIZOPHRENIA RESEARCH
    3. Boku, N; Ohtsu, A; Nagashima, F; Muto, M; Shinkai, T; Yoshida, S
      Retrospective study of hyponatremia in gastric cancer patients treated with a combination chemotherapy of 5-fluorouracil and cisplatin: a possible warning sign of severe hematological toxicities?

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    4. Kurata, T; Tamura, T; Shinkai, T; Ohe, Y; Kunitoh, H; Kodama, T; Kakinuma, R; Matsumoto, T; Kubota, K; Omatsu, H; Nishiwaki, Y; Saijo, N
      Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    5. Ohmori, O; Shinkai, T; Hori, H; Nakamura, J
      Novel polymorphism in the 5 '-upstream region of the human 5-HT6 receptor gene and schizophrenia

      NEUROSCIENCE LETTERS
    6. Hori, H; Ohmori, O; Shinkai, T; Kojima, H; Nakamura, J
      Clara cell secretory protein (CC16) gene polymorphism and schizophrenia inhumans

      NEUROSCIENCE LETTERS
    7. Kunitoh, H; Akiyama, Y; Kusaba, H; Yamamoto, N; Sekine, I; Ohe, Y; Kubota, K; Tamura, T; Shinkai, T; Kodama, T; Goto, K; Niho, S; Nishiwaki, Y; Saijo, N
      A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer

      LUNG CANCER
    8. Hori, H; Ohmori, O; Shinkai, T; Kojima, H; Nakamura, J
      Association between three functional polymorphisms of dopamine D2 receptorgene and tardive dyskinesia in schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    9. Hori, H; Ohmori, O; Shinkai, T; Kojima, H; Nakamura, J
      Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    10. Imada, G; Shinkai, T; Masuda, W; Yatsui, K
      Influences of floating particles produced by high-pressure, pulsed glow discharge on excimer laser excitation

      JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS
    11. Imai, T; Sasaki, Y; Shinkai, T; Ohishi, H; Nezu, K; Nishimoto, Y; Ichiba, N; Yamane, T; Yoshikawa, M; Narita, N; Uchida, H
      Clinical evaluation of Tc-99m-Technegas SPECT in thoracoscopic lung volumereduction surgery in patients with pulmonary emphysema

      ANNALS OF NUCLEAR MEDICINE
    12. Hori, H; Ohmori, O; Shinkai, T; Kojima, H; Okano, C; Suzuki, T; Nakamura, J
      Manganese superoxide dismutase gene polymorphism and schizophrenia: Relation to tardive dyskinesia

      NEUROPSYCHOPHARMACOLOGY
    13. Umegaki, H; Tamaya, N; Shinkai, T; Iguchi, A
      The metabolism of plasma glucose and catecholamines in Alzheimer's disease

      EXPERIMENTAL GERONTOLOGY
    14. Nakamura, Y; Kunitoh, H; Kubota, K; Sekine, I; Shinkai, T; Tamura, T; Kodama, T; Sumi, M; Kohno, S; Saijo, N
      Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    15. Fujishiro, M; Shinkai, T; Fukuda, M; Tamura, T; Ohe, Y; Kunitoh, H; Nishiwaki, Y; Sekine, I; Fukuda, H; Saijo, N
      Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    16. Ohmori, O; Shinkai, T; Hori, H; Kojima, H; Nakamura, J
      Synapsin III gene polymorphisms and schizophrenia

      NEUROSCIENCE LETTERS
    17. Terao, T; Nakamura, J; Yoshimura, R; Ohmori, O; Takahashi, N; Shinkai, T
      Prediction of lithium response using m-chlorophenylpiperazine challenge test: a preliminary finding

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    18. Terao, T; Nakamura, J; Yoshimura, R; Ohmori, O; Takahashi, N; Kojima, H; Soeda, S; Shinkai, T; Nakano, H; Okuno, T
      Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women

      PSYCHIATRY RESEARCH
    19. Ohmori, O; Shinkai, T; Suzuki, T; Okano, C; Kojima, H; Terao, T; Nakamura, J
      Polymorphisms of the sigma(1) receptor gene in schizophrenia: An association study

      AMERICAN JOURNAL OF MEDICAL GENETICS
    20. Shinkai, T
      Second mover disadvantages in a three-player Stackelberg game with privateinformation

      JOURNAL OF ECONOMIC THEORY
    21. Shinkai, T; Nakashima, M; Ohmori, O; Terao, T; Nakamura, J; Hiramatsu, N; Hashiguchi, H; Tsuji, S
      Coenzyme Q(10) improves psychiatric symptoms in adult-onset mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a case report

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    22. Sekine, I; Tamura, T; Kunitoh, H; Kubota, K; Shinkai, T; Kamiya, Y; Saijo, N
      Progressive disease rate as a surrogate endpoint of phase II trials for non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    23. Shinkai, T; Roth, GS
      Mechanisms of age-related changes in gonadotropin-releasing hormone receptor messenger ribonucleic acid content in the anterior pituitary of male rats

      EXPERIMENTAL GERONTOLOGY
    24. Terao, T; Okuno, K; Okuno, T; Nakano, H; Shinkai, T; Ohmori, O; Yoshimura, R; Suzuki, T; Abe, K
      A simpler and more accurate equation to predict daily lithium dose

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    25. Ohmori, O; Kojima, H; Shinkai, T; Terao, T; Suzuki, T; Abe, K
      Genetic association analysis between CYP2D6*2 allele and tardive dyskinesia in schizophrenic patients

      PSYCHIATRY RESEARCH
    26. Kojima, H; Ohmori, O; Shinkai, T; Terao, T; Suzuki, T; Abe, H
      Dopamine D1 receptor gene polymorphism and schizophrenia in Japan

      AMERICAN JOURNAL OF MEDICAL GENETICS
    27. Shinkai, T; Ohmori, O; Kojima, H; Terao, T; Suzuki, T; Abe, K
      Association study of the 5-HT6 receptor gene in schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    28. Kunitoh, H; Sekine, I; Kubota, K; Tamura, T; Shinkai, T; Kodama, T; Saijo, N; Naruke, T; Yamaguchi, N
      Histologic types of lung carcinoma and related family history of anatomic sites and histologic types of cancers

      CANCER
    29. Terao, T; Ohmori, O; Shinkai, T
      A puzzling case of seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration

      ACTA PSYCHIATRICA SCANDINAVICA
    30. Umekage, T; Yuu, S; Shinkai, T; Abe, T
      Numerical simulation for blockage of cohesive particles in a hopper using the distinct element method and its correlation with experimental results of real cohesive granular materials

      ADVANCED POWDER TECHNOLOGY
    31. OHMORI O; SUZUKI T; KOJIMA H; SHINKAI T; TERAO T; MITA T; ABE K
      TARDIVE-DYSKINESIA AND DEBRISOQUINE 4-HYDROXYLASE (CYP2D6) GENOTYPE IN JAPANESE SCHIZOPHRENICS

      Schizophrenia research
    32. ABE K; WAKAO F; OYAMA H; MIZUSHIMA H; SHINKAI T; ISHIKAWA KB; WATANABE T; MORIYAMA N; YAMAGUCHI N
      INFORMATION TECHNOLOGY AT THE NATIONAL-CANCER-CENTER

      Japanese Journal of Clinical Oncology
    33. KASAI T; OHE Y; NISHIO K; KUNITOH H; TAMURA T; SEKINE I; KUBOTA K; YAMAMOTO N; NAKAMURA Y; SHINKAI T; KODAMA T; SAIJO N
      FACTORS THAT INFLUENCE THE ELIGIBILITY OF CASES FOR INCLUSION IN CLINICAL-TRIALS

      Japanese Journal of Clinical Oncology
    34. Shinkai, T; Abe, K; Ebihara, S; Mizushima, H; Wakao, F; Ishikawa, KB; Yamaguchi, N
      Cancer information from the National Cancer Center, Japan

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    35. Sasaki, Y; Imai, T; Shinkai, T; Ohishi, H; Otsuji, H; Uchida, H; Tokuyama, T; Hamada, K; Narita, N
      Estimation of regional lung function in interstitial pulmonary disease using Tc-99m-Technegas and Tc-99m-macroaggregated albumin single-photon emission tomography

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    36. SUGIYAMA K; SHINKAI T; WASEDA Y
      STRUCTURAL STUDY OF MOLTEN ALBITE (NAALSI3O8) BY THE HIGH-TEMPERATUREENERGY-DISPERSIVE X-RAY-DIFFRACTION (EDXD) METHOD

      High-temperature materials and processes
    37. SHINKAI T; OHMORI O; KOJIMA H; TERAO T; SUZUKI T; ABE K; NAKAMURA J
      APOLIPOPROTEIN-E REGULATORY REGION GENOTYPE IN SCHIZOPHRENIA

      Neuroscience letters
    38. OHMORI O; SHINKAI T; KOJIMA H; TERAO T; SUZUKI T; MITA T; ABE K
      ASSOCIATION STUDY OF A FUNCTIONAL CATECHOL-O-METHYLTRANSFERASE GENE POLYMORPHISM IN JAPANESE SCHIZOPHRENICS

      Neuroscience letters
    39. SHINKAI T; OHMORI O; KOJIMA H; TERAO T; SUZUKI T; ABE K
      ASSOCIATION STUDY OF THE 5-HT6 RECEPTOR GENE IN SCHIZOPHRENIA

      American journal of medical genetics
    40. SHINKAI T; OHMORI O; KOJIMA H; TERAO T; SUZUKI T; ABE K
      NEGATIVE ASSOCIATION BETWEEN T102C POLYMORPHISM OF THE 5-HT2A RECEPTOR GENE AND SCHIZOPHRENIA IN JAPAN

      Human heredity
    41. MURAYAMA K; SHINKAI T; KATSUKI S; AKIYAMA H
      GAS-PUFF Z-PINCH PLASMAS DRIVEN BY INDUCTIVE ENERGY-STORAGE PULSED-POWER GENERATOR

      JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS
    42. OKUSAKA T; EGUCHI K; KASAI T; KURATA T; YAMAMOTO N; OHE Y; TAMURA T; SHINKAI T; SAIJO N
      SERUM LEVELS OF PRO-GASTRIN-RELEASING PEPTIDE FOR FOLLOW-UP OF PATIENTS WITH SMALL-CELL LUNG

      Clinical cancer research
    43. SHINKAI T; ZHANG L; MATHIAS SA; ROTH GS
      DOPAMINE INDUCES APOPTOSIS IN CULTURED RAT STRIATAL NEURONS - POSSIBLE MECHANISM OF D-2-DOPAMINE RECEPTOR NEURON LOSS DURING AGING

      Journal of neuroscience research
    44. YAMAMOTO N; TAMURA T; OHE Y; OSHITA F; KASAI T; KURATA T; SHINKAI T; EGUCHI K; SAIJO N
      CHRONOPHARMACOLOGY OF ETOPOSIDE GIVEN BY LOW-DOSE PROLONGED INFUSION IN LUNG-CANCER PATIENTS

      Anticancer research
    45. ANDO M; EGUCHI K; SHINKAI T; TAMURA T; OHE Y; YAMAMOTO N; KURATA T; KASAI T; OHMATSU H; KUBOTA K; SEKINE I; HOJO N; MATSUMOTO T; KODAMA T; KAKINUMA R; NISHIWAKI Y; SAIJO N
      PHASE-I STUDY OF SEQUENTIALLY ADMINISTERED TOPOISOMERASE-I INHIBITOR (IRINOTECAN) AND TOPOISOMERASE-II INHIBITOR (ETOPOSIDE) FOR METASTATICNON-SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    46. KATSUMATA N; EGUCHI K; FUKUDA M; YAMAMOTO N; OHE Y; OSHITA F; TAMURA T; SHINKAI T; SAIJO N
      SERUM LEVELS OF CYTOKINES IN PATIENTS WITH UNTREATED PRIMARY LUNG-CANCER

      Clinical cancer research
    47. SAKURAGI T; OSHITA F; NAGASHIMA S; KASAI T; KURATA T; FUKUDA M; YAMAMOTO N; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      RETROSPECTIVE ANALYSIS OF THE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER SHOWING POOR PERFORMANCE STATUS

      Japanese Journal of Clinical Oncology
    48. SAIJO N; NISHIO K; OHTA S; ARIOKA H; FUNAYAMA Y; FUKUOKA K; KUROKAWA H; NOMOTO T; ISHIDA T; YAMAMOTO N; TAMURA T; SHINKAI T; EGUCHI K; OHE Y; KUNITO H; OHTSU T; SASAKI Y
      PROGRESS IN PRECLINICAL AND CLINICAL-STUDIES FOR THE DEVELOPMENT OF NEW ANTICANCER DRUGS IN JAPAN, WITH EMPHASIS ON TAXANES

      Cancer chemotherapy and pharmacology
    49. SUGIYAMA K; SHINKAI T; WASEDA Y
      NEW ADXD EDXD SPECTROMETER FOR DETERMINING THE STRUCTURE OF MELTS AT HIGH-TEMPERATURE/

      Science Reports of the Research Institutes, Tohoku University, Series A: Physics, Chemistry, and Metallurgy
    50. OSHITA F; KURATA T; KASAI T; FUKUDA M; YAMAMOTO N; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      PROSPECTIVE EVALUATION OF THE FEASIBILITY OF CISPLATIN-BASED CHEMOTHERAPY FOR ELDERLY LUNG-CANCER PATIENTS WITH NORMAL ORGAN FUNCTIONS

      Japanese journal of cancer research
    51. SASAKI Y; HAKUSUI H; MIZUNO S; MORITA M; MIYA T; EGUCHI K; SHINKAI T; TAMURA T; OHE Y; SAIJO N
      A PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF CPT-11 AND ITS ACTIVE METABOLITE SN-38

      Japanese journal of cancer research
    52. OSHITA F; KASAI T; KURATA T; FUKUDA M; YAMAMOTO N; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      INTENSIVE CHEMOTHERAPY WITH CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE,ETOPOSIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR FOR ADVANCED THYMOMA OR THYMIC CANCER - PRELIMINARY-RESULTS

      Japanese Journal of Clinical Oncology
    53. YAMAMOTO N; TAMURA T; MAEDA M; ANDO M; SHINKAI T; EGUCHI K; OHE Y; OSHITA F; SHIRAISHI J; KATSUMATA N; SAIJO N
      THE INFLUENCE OF AGING ON CISPLATIN PHARMACOKINETICS IN LUNG-CANCER PATIENTS WITH NORMAL ORGAN FUNCTION

      Cancer chemotherapy and pharmacology
    54. SHINKAI T; OOKA H
      EFFECT OF ANGIOTENSIN-II ON THE PROLIFERATION OF MAMMOTROPHS FROM THEADULT-RAT ANTERIOR-PITUITARY IN CULTURE

      Peptides
    55. NAKASHIMA H; LIEBERMAN R; KARATO A; ARIOKA H; OHMATSU H; NOMURA N; SHIRAISHI J; TAMURA T; EGUCHI K; SHINKAI T; SASAKI Y; YAMAMOTO N; HUKUDA M; OSHITA F; OHE Y; SAIJO N
      EFFICIENT SAMPLING STRATEGIES FOR FORECASTING PHARMACOKINETIC PARAMETERS OF IRINOTECAN (CPT-11) - IMPLICATION FOR AREA UNDER THE CONCENTRATION-TIME CURVE MONITORING

      Therapeutic drug monitoring
    56. SHINKAI T; SAKURAI Y; OOKA H
      AGE-RELATED-CHANGES IN THE NUMBERS OF MAMMOTROPHS, SOMATOTROPHS AND MAMMOSOMATOTROPHS IN THE ANTERIOR-PITUITARY GLAND OF FEMALE RATS - A FLOW CYTOMETRIC STUDY

      Mechanism of ageing and development
    57. OSHITA F; YAMAMOTO N; FUKUDA M; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      CORRELATION OF THERAPEUTIC OUTCOME IN NONSMALL CELL LUNG-CANCER AND DNA-DAMAGE ASSAYED BY POLYMERASE CHAIN-REACTION IN LEUKOCYTES DAMAGED IN-VITRO

      Cancer research
    58. EGUCHI K; ETOU H; MIYACHI S; MORINARI H; NAKADA K; NODA K; OHKUNI Y; WATANABE K; YAMADA Y; OHE Y; TAMURA T; SASAKI Y; SHINKAI T; SAIJO N
      STUDY OF DOSE-ESCALATION OF TENIPOSIDE (VM-26) PLUS CISPLATIN (CDDP) WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF)IN PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER

      European journal of cancer
    59. YAMAMOTO N; TAMURA T; KARATO A; UENAKA K; EGUCHI K; SHINKAI T; OHE Y; OSHITA F; ARIOKA H; NAKASHIMA H; SHIRAISHI J; FUKUDA M; HIGUCHI S; SAIJO N
      CPT-11 - POPULATION PHARMACOKINETIC MODEL AND ESTIMATION OF PHARMACOKINETICS USING THE BAYESIAN METHOD IN PATIENTS WITH LUNG-CANCER

      Japanese journal of cancer research
    60. OHMATSU H; EGUCHI K; SHINKAI T; TAMURA T; OHE Y; NISIO M; KUNIKANE H; ARIOKA H; KARATO A; NAKASHIMA H; SASAKI Y; TAJIMA K; TADA N; SAIJO N
      A RANDOMIZED CROSS-OVER STUDY OF HIGH-DOSE METOCLOPRAMIDE PLUS DEXAMETHASONE VERSUS GRANISETRON PLUS DEXAMETHASONE IN PATIENTS RECEIVING CHEMOTHERAPY WITH HIGH-DOSE CISPLATIN

      Japanese journal of cancer research
    61. TAMURA T; SASAKI Y; EGUCHI K; SHINKAI T; OHE Y; NISHIO M; KUNIKANE H; ARIOKA H; KARATO A; OMATSU H; NAKASHIMA H; SAIJO N
      PHASE-I AND PHARMACOKINETIC STUDY OF PACLITAXEL BY 24-HOUR INTRAVENOUS-INFUSION

      Japanese journal of cancer research
    62. KOGA H; EGUCHI K; SHINKAI T; TAMURA T; OHE Y; OSHITA F; SAIJO N; KONDO H; OKI K; OKURA H
      PRELIMINARY EVALUATION OF THE NEW TUMOR-MARKER, CYFRA-21-1, IN LUNG-CANCER PATIENTS

      Japanese Journal of Clinical Oncology
    63. SAIJO N; NISHIO K; KUBOTA N; KANZAWA F; SHINKAI T; KARATO A; SASAKI Y; EGUCHI K; TAMURA T; OHE Y; OSHITA F; NISHIO M
      7-ETHYL-10-[4-(1-PIPERIDINO)-1-PIPERIDINO] CARBONYLOXY CAMPTOTHECIN -MECHANISM OF RESISTANCE AND CLINICAL-TRIALS

      Cancer chemotherapy and pharmacology
    64. KOJIMA A; SHINKAI T; SOEJIMA Y; OKAMOTO H; EGUCHI K; SASAKI Y; TAMURA T; OSHITA F; OHE Y; SAIJO N
      A RANDOMIZED PROSPECTIVE-STUDY OF IMIPENEM-CILASTATIN WITH OR WITHOUTAMIKACIN AS AN EMPIRICAL ANTIBIOTIC-TREATMENT FOR FEBRILE NEUTROPENICPATIENTS

      American journal of clinical oncology
    65. SHINKAI T; TAMURA T; SANO T; KOJIMA A; EGUCHI K; SASAKI Y; OHE Y; SAIJO N
      IN-VITRO AND IN-VIVO CYTOGENETIC EFFECTS OF RECOMBINANT INTERLEUKIN-2ON HUMAN-LYMPHOCYTES

      American journal of clinical oncology
    66. SAIJO N; EGUCHI K; ETOU H; MIYACHI S; MORINARI H; NAKADA K; NODA K; OHKUNI Y; WATANABE K; YAMADA Y; KABE J; KUDO S; MANO K; MORINARI H; TANAKA T; UZAWA T; OHE Y; TAMURA T; SASAKI Y; SHINKAI T
      THE ROLE OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN CHEMOTHERAPY FOR LUNG-CANCER

      Seminars in oncology
    67. KVITNITSKAYARYZHOVA T; SHINKAI T; OOKA H; OHTSUBO K
      IMMUNOCYTOCHEMICAL DEMONSTRATION OF PROLACTIN INTERACTION WITH CHOROID-PLEXUS IN AGING AND ACUTE HYPERPROLACTINEMIA

      Mechanism of ageing and development
    68. SHINKAI T; ARIOKA H; KUNIKANE H; EGUCHI K; SASAKI Y; TAMURA T; OHE Y; OSHITA F; NISHIO M; KARATO A; OKAMOTO H; NAKASHIMA H; OHMATSU H; SHIRAISHI J; NOMURA N; SAIJO N
      PHASE-I CLINICAL-TRIAL OF IRINOTECAN (CPT-11), PIPERIDINO)-1-PIPERIDINO]CARBONYLOXY-CAMPTOTHECIN, AND CISPLATIN IN COMBINATION WITH FIXED-DOSE OF VINDESINE IN ADVANCED NONSMALL CELL LUNG-CANCER

      Cancer research
    69. KARATO A; SASAKI Y; SHINKAI T; EGUCHI K; TAMURA T; OHE Y; OSHITA F; NISHIO M; KUNIKANE H; ARIOKA H; OHMATSU H; NAKASHIMA H; SHIRAISHI J; SAIJO N
      PHASE-I STUDY OF CPT-11 AND ETOPOSIDE IN PATIENTS WITH REFRACTORY SOLID TUMORS

      Journal of clinical oncology
    70. KOJIMA A; SHINKAI T; SAIJO N
      CYTOGENETIC EFFECTS OF CPT-11 AND ITS ACTIVE METABOLITE, SN-38 ON HUMAN-LYMPHOCYTES

      Japanese Journal of Clinical Oncology
    71. YANO K; YOSHIDA Y; SHINKAI T; KANEKO M
      A PRACTICAL METHOD FOR THE CONCENTRATION OF VIRUSES FROM WATER USING FIBRIFORM CELLULOSE AND ORGANIC COAGULANT

      Water science and technology
    72. OKAMOTO H; SHINKAI T; MATSUNO Y; SAIJO N
      INTRADURAL PARENCHYMAL INVOLVEMENT IN THE SPINAL SUBARACHNOID SPACE ASSOCIATED WITH PRIMARY LUNG-CANCER

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 22:35:30